However, restoration of PC syn-thesis to normal levels by increasing the expression of cholinephosphotransferase did not alter the ability of farnesol to cause apoptosis, and the additio
Trang 1phospholipase D signal transduction
Marcia M Taylor1, Kendra MacDonald1, Andrew J Morris2and Christopher R McMaster1
1 Atlantic Research Centre, Dalhousie University, Halifax, Canada
2 Department of Cell and Developmental Biology, Lineberger Comprehensive Cancer Center, The University of North Carolina at Chapel Hill, USA
Phosphatidylcholine (PC) is the major membrane lipid
found in eukaryotic cells, comprising 50% of
phos-pholipid mass PC plays a major role in maintaining
the physical properties of membranes and is also a
res-ervoir of signaling molecules [1–4] A major signal
transduction pathway initiated from PC is its
catabol-ism by phospholipase D (PLD) to yield phosphatidic
acid (PA), which can be dephosphorylated by PA
phosphatase activity to generate diacylglycerol (DAG)
(Fig 1) [3,5–14] Both PA and DAG can directly bind
to proteins within the cell and modulate numerous
cellular events including those that regulate apoptotic
life-and-death decisions [2,4,15] Apoptosis is normally
required during development as well as in the removal
of adult cells that have reached the end of their normal
lifespan Misregulation of the apoptotic process
contri-butes to tumorgenicity and many cancer chemo-therapeutics preferentially induce apoptosis in cancer cells [16]
Farnesol is a natural compound whose exogenous administration has been observed to preferentially cause apoptosis in neoplastic vs normal cells [17,18] Farnesol is produced by dephosphorylation of farnesol pyrophosphate, a metabolite of the cholesterol biosyn-thetic pathway [19] Farnesol pyrophosphate can also
be used to donate farnesol for covalent prenylation of proteins and is an essential process for oncogenic Ras
to affect cellular tranformation [20,21] The ability of farnesol administration to alter the prenylation of the small G proteins Ras and Rap1A has been previously tested and neither the prenylation event nor the ability
of the G proteins to associate with the membrane was
Keywords
apoptosis; diacylglycerol; farnesol;
phosphatidic acid phosphatase;
phospholipase D
Correspondence
C McMaster, Atlantic Research Centre,
Departments of Pediatrics and Biochemistry
& Molecular Biology, Dalhousie University,
5849 University Avenue, Room C302,
Halifax, Nova Scotia B3H 4H7, Canada
Fax: +1 902 494 1394
Tel: +1 902 494 2953
E-mail: Christopher.mcmaster@dal.ca
(Received 15 May 2005, revised 3 August
2005, accepted 11 August 2005)
doi:10.1111/j.1742-4658.2005.04914.x
Farnesol is a catabolite of the cholesterol biosynthetic pathway that prefer-entially causes apoptosis in tumorigenic cells Phosphatidylcholine (PC), phosphatidic acid (PA), and diacylglycerol (DAG) were able to prevent induction of apoptosis by farnesol Primary alcohol inhibition of PC cata-bolism by phospholipase D augmented farnesol-induced apoptosis Exogen-ous PC was unable to prevent the increase in farnesol-induced apoptosis by primary alcohols, whereas DAG was protective Farnesol-mediated apopto-sis was prevented by transformation with a plasmid coding for the PA phosphatase LPP3, but not by an inactive LPP3 point mutant Farnesol did not directly inhibit LPP3 PA phosphatase enzyme activity in an in vitro mixed micelle assay We propose that farnesol inhibits the action of a DAG pool generated by phospholipase D signal transduction that nor-mally activates an antiapoptotic⁄ pro-proliferative target
Abbreviations
CHO, Chinese hamster ovary; DAG, diacylglycerol; DMEM, Dulbecco’s modified Eagle’s medium; FBS, fetal bovine serum; LPP, lipid phosphate phosphatase; PA, phosphatidic acid; PARP, polyADP-ribose polymerase; PC, phosphatidylcholine; PLD, phospholipase D; RasGEF, Ras guanine exchange factor; TBS, Tris-buffered saline.
Trang 2altered [22] Thus, it appears that farnesol
administra-tion preferentially kills transformed cells by a
mechan-ism independent of protein prenylation
Previous studies found that the addition of PC, but
not other phospholipids, was able to rescue cells from
farnesol-mediated apoptosis [23,24] PC was much less
effective at preventing apoptosis induced by
campto-thecin, etoposide, or chelerythrine [23] implying that
some specificity for farnesol exists It was hypothesized
that farnesol inhibition of cholinephosphotransferase,
the final step in PC synthesis, was the apoptotic trigger
[22,23] as farnesol-mediated apoptosis could be
preven-ted by the exogenous addition of the
cholinephospho-transferase substrate DAG, or its product, PC, but not
by other lipids [23] However, restoration of PC
syn-thesis to normal levels by increasing the expression of
cholinephosphotransferase did not alter the ability of
farnesol to cause apoptosis, and the addition of DAG
to cells did not prevent farnesol-mediated inhibition of
PC synthesis, indicating that inhibition of PC synthesis
by farnesol was not the apoptotic trigger [24]
Analysis of the PC metabolic pathways also links PC
to DAG through hydrolysis by PLD to produce PA
and subsequent dephosphorylation to DAG [2,3,7] As
the generation of PA and DAG by lipid turnover is a
major means by which cells regulate cell growth we
reasoned that this pathway may be a major contributor
to the signal required for farnesol to induce apoptosis
Results Inhibition of PLD augments farnesol-mediated apoptosis
PLD hydrolysis of PC is via a transphosphatidylation reaction using water as the second substrate for the generation of PA It has been well characterized that primary alcohols can substitute for water resulting in the formation of a phosphatidylalcohol instead of PA [3] Phosphatidylalcohols are not substrates for PA phosphatases and consequently inhibit the metabolic pathway through the production of a very poorly metabolized intermediate The affinity of PLD for alcohol is limited to primary alcohols, whereas secon-dary alcohols are not utilized by PLD Thus, the addi-tion of primary alcohols to cells in culture effectively inhibits PLD-mediated signaling as the generation of phosphatidylalcohol substantially reduces the forma-tion of PA and its subsequent metabolism to DAG [25–27] Farnesol addition results in apoptosis in Chi-nese hamster ovary cells (CHO-K1) (Fig 2A) and we observed that the addition of primary, but not secon-dary, alcohols exacerbated farnesol-induced apoptosis (Fig 2B) Neither primary nor secondary alcohols alone resulted in the appearance of condensed nuclei
or positive Annexin V stain above control levels imply-ing that farnesol is augmentimply-ing apoptosis when prod-uct formation by PLD is reduced (Fig 2B) Although not quantitative, we also assessed cleavage of poly-ADP-ribose polymerase (PARP) and caspase 3 subse-quent to the addition of farnesol to ensure that the observed cell death was indeed apoptotic Farnesol resulted in cleavage of both PARP and caspase 3 (Fig 2C,D) The addition of isopropanol or propanol did not result in PARP or caspase cleavage unless farnesol was also present, indicating that the cell death observed was apoptotic
Dissecting the role of phospholipids in the PLD signaling pathway
We next determined the ability of PC (upstream of the alcohol block) and DAG (downstream of the alcohol block of PLD) to rescue cells from the augmentation
of farnesol-induced apoptosis by primary alcohols In the presence of primary alcohols DAG, but not PC, rescued farnesol-mediated apoptosis (Fig 3A) Farne-sol uptake, using radiolabeled farneFarne-sol as a probe, was not altered by the exogenous addition of these
Fig 1 DAG consumption for the synthesis of PC and PLD
medi-ated turnover for the generation of a DAG-signaling pool DAG
util-ization during the synthesis of PC takes place in the nuclear
membrane ⁄ endoplasmic reticulum and the Golgi, while
PLD-medi-ated turnover of PC for the production of a DAC occurs primarily at
the plasma membrane.
Trang 3glycerolipids (data not shown) indicating that it is the glycerolipids themselves that are providing resistance
to farnesol
Although a large number of lipids had been tested for protective properties with respect to farnesol-induced apoptosis, the PLD signaling intermediate
PA was not among the published candidates When exogenous PA was added to CHO-K1 cells prior to the addition of farnesol it was found to be protect-ive in a concentration-dependent manner (Fig 3B) The data imply that PC is metabolized through PLD and PA phosphatase resulting in the generation of a DAG pool that contributes to a cellular proliferation signal, and farnesol inhibits generation of, or signa-ling by, this DAG pool However, some studies have indicated that (lyso)PA can be dephosphorylated by cell-surface lipid phosphate phosphatases (LPP) making it difficult to establish a role for PA signa-ling in biological processes through the addition of exogenous lipid [28,29] In addition, it is difficult to compare exogenous lipid uptake, distribution, and metabolism within a cell Although our lipid rescue data strongly imply that farnesol is affecting signa-ling by the PLD⁄ PA phosphatase pathway, we per-formed cell transfection experiments to more directly address this possibility
Active GFP-fusions to open reading frames coding for the two isoforms of PLD (PLD1 and PLD2) [9,10,30–32] and the coupled phosphatidic acid phos-phatase (LPP3) [33], along with a catalytically inactive LPP3 point-mutant [34], were transiently transfected into CHO-K1 cells The cells were then treated with farnesol and the transfectants positive for enzyme overexpression (as detected by the presence of green fluorescence) were analyzed for apoptosis (Fig 3C) Increasing PLD1 reduced farnesol-induced apoptosis
by nearly 30% and PLD2 overexpression reduced farnesol-induced apoptosis by 60% Overexpression
of LPP3, but not its inactive mutant, completely pre-vented farnesol-induced apoptosis To determine if farnesol was a direct inhibitor of LPP activity, the PLD-coupled PA phosphatase LPP3 was expressed
in Baculovirus and assayed for activity using a Triton X-100 mixed micelle assay [35] Farnesol was a very poor inhibitor of LPP3 activity as the maximal inhibition observed was 16.5% at 100 lm farnesol (data not shown)
Evidence for a DAG responsive target The data argue that farnesol is inhibiting a DAG-responsive target required for life, and that the PLD⁄ PA phosphatase pathway contributes
meaning-A
B
C
D
Fig 2 Farnesol-induced apoptosis in cells incubated with primary
alcohols and rescue by phospholipids CHO-K1 cells were incubated
for 4 h with 80 l M farnesol (delivered in dimethylsulfoxide at a final
concentration of 0.1% into DMEM supplemented with FBS) (A)
Cells were then stained with Ho¨echst 33258 or Annexin V and
imaged as described in Experimental procedures (B) The effect of
increasing concentrations of isopropanol or propanol on
farnesol-induced apoptosis Apoptosis was determined by imaging at least
three random fields of 300 cells in triplicate for both Ho¨echst 33258
and Annexin V apoptosis-positive signals Data are the mean ± SD
of at least three separate experiments (C) Farnesol-induced
clea-vage of PARP from its parental form to the caspase-cleaved form.
Farnesol was delivered at 80 l M and alcohols were present at 1%
(v ⁄ v) (D) Farnesol-induced generation of the caspase-cleaved form
of caspase 3 Farnesol was delivered at 80 l M and alcohols were
present at 1% (v ⁄ v).
Trang 4fully to this DAG pool Phorbol esters are
non-metabolizable DAG mimics that bind to proteins
containing specific C1 domains and activate a similar
set of proteins as DAG [4,36] To test if
farnesol-mediated apoptosis required further metabolism of
DAG, or if the target of the pathway was a DAG
binding protein, we added phorbol ester to cells in
the presence or absence of farnesol The C1 domain
binding phorbol ester, b-TPA, inhibited
farnesol-mediated apoptosis while its inactive isomer a-TPA
did not (Fig 4) Neither phorbol ester alone altered
apoptosis
Discussion Farnesol is a catabolite of the cholesterol⁄ isoprenoid biosynthetic pathway whose administration preferen-tially induces apoptosis in transformed vs untrans-formed cells or in tissues taken from cancer patients as
Fig 4 Effect of phorbol esters on farnesol-induced apoptosis CHO-K1 cells incubated with DMEM for 60 min were pretreated with 100 n M a-TPA or b-TPA for 30 min and then incubated for 2 h with or without 40 l M farnesol (into DMEM delivered in 0.1% dimethylsulfoxide) Apoptosis was determined by imaging at least three random fields of 300 cells in triplicate for both Ho¨echst 33258 and Annexin V apoptosis positive signals The mean ± SEM of four separate experiments is shown.
A
B
C
Fig 3 Role of the PLD pathway in farnesol-induced apoptosis (A) CHO-K1 cells were preincubated with 65 l M di18 : 1 PC or 65 l M
di18 : 1 DAG for 30 min The cells were then incubated under the same conditions for 4 h with 0, 50, 100 or 150 m M propanol and with 80 l M farnesol (delivered in 0.1% dimethylsulfoxide) Apopto-sis was determined by imaging at least three random fields of 300 cells in triplicate for both Ho¨echst 33258 and Annexin V apoptosis positive signals The mean ± SD of at least three separate experi-ments is shown Student’s two-tailed t-test was used to determine significant differences (*P < 0.05 from control) (B) CHO-K1 med-ium was replaced by DMEM 60 min prior to the experiment and cells were preincubated with increasing concentrations of phos-phatidic acid added for 15 min The cells were then incubated under the same conditions for 4 h with 80 l M farnesol (delivered in dimethylsulfoxide at a final concentration of 0.1% into DMEM sup-plemented with FBS) The cells were stained with Ho¨echst 33258
or Annexin V to assess apoptosis The mean ± SD of at least four separate experiments is shown Student’s two-tailed t-test was used to determine significant differences (*P < 0.05 from no phos-phatidic acid addition) (C) CHO-K1 cells were transfected with vectors containing GFP-tagged constructs of LPP3, a catalytically inactive LPP3 mutant, PLD1, and PLD2 The parent vector, pEGFP (GFP), was used as a control Growth medium was replaced with DMEM 30 min prior to addition of farnesol at a final concentration
of 40 l M (in 0.1% dimethylsulfoxide) for 2 h The cells were then stained with Ho¨echst 33258 or Annexin V and apoptosis was quantitated Only cells positive for transfection were analyzed The mean ± SEM of three separate experiments is shown.
Trang 5opposed to healthy control subjects [17,19,37] We
observed that inhibition of PLD signaling augmented
farnesol-induced apoptosis, whereas secondary alcohols
had no effect on the level of farnesol-induced
apopto-sis Consistent with the importance of DAG signaling
is the requirement for PLD conversion of PC to DAG
for effective inhibition of farnesol-induced apoptosis
PA, the intermediate in the PLD signaling pathway,
was also capable of preventing farnesol-induced
apop-tosis Our evidence implicated PLD signaling as a key
mediator of farnesol-induced apoptosis
Overexpression of the PA phosphatase LPP3
pre-vented farnesol-mediated apoptosis A catalytically
inactive LPP3 point mutant was unable to do so,
essentially ruling out protein–protein interactions or
physical properties of protein overexpression as the
cause of rescue By comparison, expression of PLD1
or PLD2 resulted in a small decrease in
farnesol-induced apoptosis [8,10,30,34] Because LPP3 was the
only enzyme in the PLD signaling pathway capable of
substantial inhibition of farnesol-induced apoptosis by
overexpression, and as we demonstrated that this was
not by direct inhibition of LPP3 enzymatic activity by
farnesol, this likely means that: (a) LPP3 is the
rate-limiting enzyme for production of the
farnesol-access-ible DAG pool, and (b) increased flux through this
pathway is able to protect cells from farnesol-induced
apoptosis by shifting the balance of life-and-death
sig-nals away from apoptosis Our results predict that
farnesol is inhibiting a PLD⁄ LPP3-generated DAG
signaling pool If augmentation of DAG signaling is
the key to preventing farnesol-induced apoptosis, it
follows that PC rescues farnesol-induced apoptosis
only after it has been broken down into a molecule of
DAG Indeed, we observed that primary alcohol
aug-mentation of farnesol-mediated apoptosis could be
pre-vented by the addition of DAG but not PC
Consistent with this interpretation was the
observa-tion that the nonmetabolizable DAG mimetic b-TPA, a
pharmacological agent widely used to activate
DAG-responsive PKC enzymes and other proteins containing
DAG-binding C1 domains [4,36,38,39], also attenuated
farnesol-induced apoptosis As DAG and b-TPA
inhib-ited farnesol-induced apoptosis this implies that farnesol
prevented direct activation of an antiapoptotic DAG
binding target The nature of this target has yet to be
uncovered but it is likely a C1-domain-containing
pro-tein that is antiapoptotic and relatively ubiquitous The
C1-domain-containing PKC family member that best
fits these criteria is PKCa as it has been generally
observed that over-expression of PKCa prevents or
attenuates apoptosis in many cell types, whereas
down-regulation of PKCa potentiates apoptosis [40–42]
Although the precise role of PKCa? in the regulation of apoptotis is not completely defined it does phosphory-late Bcl-2 on Ser70, an event required for Bcl-2 to inhibit apoptosis [43,44] Although PKCs are the most thor-oughly characterized phorbol ester receptors in cells, several other C1 domain containing proteins can also bind phorbol esters including the Rac GTPase activating protein n-chimaerin, the scaffolding protein Munc13, some DAG kinase isoforms, and Ras guanine exchange factors (RasGEFs) [45] Most notable among these are the RasGEFs, as the C1 domain of these proteins is required for their transforming potential and knockout mice display defective proliferative responses [46–48] The combined data indicate that the PLD⁄ LPP3 pathway substantially contributes to the generation
of an antiapoptotic⁄ pro-proliferative DAG pool, and signaling by this DAG pool is inhibited by farnesol The precise farnesol target remains to be determined but our evidence supports a mechanism by which farnesol inhibits DAG activation of an antiapoptotic C1-domain containing protein
Experimental procedures Cell culture and transfection The CHO-K1 cell line was obtained from the American Type Culture Collection CHO-K1 cells were maintained in a 5%
CO2 atmosphere at 37C in Dulbecco’s modified Eagle’s medium (DMEM) supplemented with 5% fetal bovine serum (FBS) and 300 lm proline CHO-K1 cells were transiently transfected using Lipofectamine (Life Technologies, Rock-ville, MD) at a density of 2· 105
cells in a 60 mm dish They were grown under normal conditions for a day Plasmid DNA (2 lg) was added to DMEM and diluted with Lipofec-tamine and the mixture was incubated for 45 min at room temperature The growth medium was removed from the cells, they were rinsed with DMEM, and the Lipofectamine mixture was overlain on top of the cells Cells were incubated for 6 h at 37C, 5% CO2, the transfection solution was removed, and medium containing 10% FBS and 33 lgÆmL)1 proline in DMEM was added to the dishes Cells were incu-bated at 37C, 5% CO2 for 24 h and the medium was replaced with DMEM supplemented with 5% FBS and
300 lm proline Cells were routinely cultured for another
24 h before analysis Lipids were sonicated in 0.1% Tri-ton X-100 and delivered to cells at a concentration not exceeding 0.001% Triton X-100 final concentration
Apoptosis determinations Nuclear morphological changes were monitored using the nuclear stain Ho¨echst 33258 Cells were grown on a cover-slip and apoptosis was induced by the desired method
Trang 6Dishes were placed on ice and the medium was aspirated.
Cells were incubated in 4% (v⁄ v) formaldehyde in NaCl ⁄ Pi
for 15 min at room temperature The cells were rinsed twice
with freshly prepared ice-cold 5 mm ammonium chloride in
NaCl⁄ Pi The dishes were then incubated for 10 min at
20C in 0.05% (w ⁄ v) Triton X-100 The dishes were rinsed
twice with NaCl⁄ Piand then incubated for 10 min at 4C
in 1% (w⁄ v) Ho¨echst 33258 in NaCl ⁄ Pi in the dark The
stain was then rinsed with NaCl⁄ Pifollowed by H2O The
coverslips were mounted and visualized with a fluorscence
microscope (Zeiss Axiovert 200) using an excitation at
365 nm and detection at 480 nm Dense nuclei (apoptotic)
were easily distinguishable from control
The externalization of phosphatidylserine was monitored
by annexin V-fluorescein staining using the
Annexin-V-FLUOS staining kit from Roche Molecular Biochemicals
(Indianapolis, IN) and visualized by fluorescence microscopy
as described with propidium iodide was used as a
counter-stain for nuclear DNA [24] At least 300 cells from three
random fields were determined for both nuclear DNA
mor-phology and annexin-V⁄ propidium iodide staining from at
least three separate experiments
Western blots
CHO-K1 cells were seeded at 5· 105cells per 60 mm dish
and grown to 80% confluency A subset of dishes was
trea-ted with 1% isopropanol or 1% propanol for 15 min at
37C and 5% CO2prior to the addition of 80 lm farnesol
in 0.1% dimethylsulfoxide, with an equal volume of
dimethylsulfoxide added to control dishes Cells were
incu-bated at 37C in 5% CO2 for 4 h, rinsed twice with cold
Tris-buffered saline (TBS), pH 7.5, and then 1 mL of 1%
Triton X-100 (v⁄ v) and CompleteOˆ protease inhibitor
cock-tail (Roche) in TBS was added Cells were incubated on ice
for 10 min and then scraped into microfuge tubes The
tubes were spun at 13 000 g for 10 min in a microfuge
Aliquots were saved for protein assay and the remaining
supernatant was precipitated using a final volume of 15%
cold acetone overnight at )20 C The acetone precipitate
was spun at 800 g in a Beckman GS-6 tabletop centrifuge
for 5 min Protein was resuspended in SDS sample buffer
to a final concentration of 20 lgÆlL)1 and resolved on a
10% or 15% SDS⁄ PAGE and transferred to polyvinylidine
difluoride membrane (Millipore Corp., Bedford, MA) To
detect PARP the membrane was incubated with anti-PARP
(Affinity BioReagents, Golden, CO, USA 1 : 1000, v⁄ v) in
10 mL 5% skim milk-TTBS (skim milk, 5% w⁄ v; 10 mL
TBS, pH 7.5; 4 lL Tween-20) overnight at 4C The blot
was rinsed in TBS and incubated with HRP-coupled
secon-dary goat anti-(mouse epitope) serum (1 : 5000, v⁄ v) in
10 mL 5% skim milk TTBS for 1 h To detect caspase 3
the blots were incubated with anticaspase 3 (Stressgen,
Col-legeville, PA, 1 : 1000, v⁄ v) in 10 mL 5% skim milk–TTBS
overnight at 4C Blots were rinsed in TBS and incubated
with HRP-coupled secondary goat anti-(rabbit epitope) serum (1 : 5000, v⁄ v) in 10 mL 5% skim milk–TTBS for
1 h Actin was probed as a loading control Blots were incubated with antiactin (Oncogene Research Products,
1 : 5000, v⁄ v) in 10 mL 5% skim milk-TTBS for 2 h After rinsing in TBS blots were incubated with HRP-coupled sec-ondary goat anti-(mouse epitope) serum (1 : 5000, v⁄ v) in
10 mL 5% skim milk–TTBS for 1 h Proteins were detected using enhanced chemiluminescence following the manufac-turer’s (Amersham Pharmacia Biotech, Piscataway, NJ) instructions
Insect cell culture and phosphatidic acid phosphatase enzyme assay
Expression of the PA phosphatase LPP3 in Sf9 cells and determination of LPP activity were exactly as described previously [35] LPP3 activity was 500–1000-fold over background
Protein and phospholipid mass determinations Protein mass was determined by the method of Lowry et al using bovine serum albumin as standard [49] Phospholipid phosphorus was determined by the method of Ames and Dubin [50]
Acknowledgements This work was supported by a grant from the Cana-dian Institutes for Health Research and a Canada Research Chair to CRM, a Nova Scotia Health Research Foundation Graduate Studentship to M.M.T., and a grant from the National Institutes of Health (GM50388) to AJM
References
1 Vance JE & Vance DE (2004) Phospholipid biosynthesis
in mammalian cells Biochem Cell Biol 82, 113–128
2 Sciorra VA & Morris AJ (2002) Roles for lipid phos-phate phosphatases in regulation of cellular signalling Biochim Biophys Acta 1582, 45–51
3 McDermott M, Wakelam MJ & Morris AJ (2004) Phos-pholipase D Biochem Cell Biol 82, 225–253
4 Newton AC (2004) Diacylglycerol’s affair with protein kinase C turns 25 Trends Pharmacol Sci 25, 175–177
5 Rizzo MA, Shome K, Vasudevan C, Stolz DB, Sung
TC, Frohman MA, Watkins SC & Romero G (1999) Phospholipase D and its product, phosphatidic acid, mediate agonist-dependent raf-1 translocation to the plasma membrane and the activation of the mitogen-activated protein kinase pathway J Biol Chem 274, 1131–1139
Trang 76 Nozawa Y (2002) Roles of phospholipase D in
apopto-sis and pro-survival Biochim Biophys Acta 1585, 77–86
7 Frohman MA, Sung TC & Morris AJ (1999)
Mamma-lian phospholipase D structure and regulation Biochim
Biophys Acta 1439, 175–186
8 McDermott MI, Sigal YJ, Sciorra VA & Morris AJ
(2004) Is PRG-1 a new lipid phosphatase? Nat Neurosci
7, 789
9 Hammond SM, Altshuller YM, Sung TC, Rudge SA,
Rose K, Engebrecht J, Morris AJ & Frohman MA
(1995) Human ADP-ribosylation factor-activated
phos-phatidylcholine-specific phospholipase D defines a new
and highly conserved gene family J Biol Chem 270,
29640–29643
10 Du G, Altshuller YM, Vitale N, Huang P,
Chasserot-Golaz S, Morris AJ, Bader MF & Frohman MA (2003)
Regulation of phospholipase D1 subcellular cycling
through coordination of multiple membrane association
motifs J Cell Biol 162, 305–315
11 Du G, Huang P, Liang BT & Frohman MA (2004)
Phospholipase D2 localizes to the plasma membrane
and regulates angiotensin II receptor endocytosis Mol
Biol Cell 15, 1024–1030
12 Sarri E, Pardo R, Fensome-Green A & Cockcroft S
(2003) Endogenous phospholipase D2 localizes to the
plasma membrane of RBL-2H3 mast cells and can be
distinguished from ADP ribosylation factor-stimulated
phospholipase D1 activity by its specific sensitivity to
oleic acid Biochem J 369, 319–329
13 Whatmore J, Morgan CP, Cunningham E, Collison KS,
Willison KR & Cockcroft S (1996) ADP-ribosylation
factor 1-regulated phospholipase D activity is localized
at the plasma membrane and intracellular organelles in
HL60 cells Biochem J 320, 785–794
14 Henneberry AL, Wright MM & McMaster CR (2002)
The major sites of cellular phospholipid synthesis and
molecular determinants of fatty acid and lipid head
group specificity Mol Biol Cell 13, 3148–3161
15 Foster DA & Xu L (2003) Phospholipase D in cell
pro-liferation and cancer Mol Cancer Res 1, 789–800
16 Makin G & Dive C (2003) Recent advances in
under-standing apoptosis: new therapeutic opportunities in
cancer chemotherapy Trends Mol Med 9, 251–255
17 Adany I, Yazlovitskaya EM, Haug JS, Voziyan PA &
Melnykovych G (1994) Differences in sensitivity to
far-nesol toxicity between neoplastically- and
non-neoplasti-cally-derived cells in culture Cancer Lett 79, 175–179
18 Rioja A, Pizzey AR, Marson CM & Thomas NS (2000)
Preferential induction of apoptosis of leukaemic cells by
farnesol FEBS Lett 467, 291–295
19 Edwards PA & Ericsson J (1999) Sterols and
isopre-noids: signaling molecules derived from the cholesterol
biosynthetic pathway Annu Rev Biochem 68, 157–185
20 Law BK, Norgaard P & Moses HL (2000)
Farnesyl-transferase inhibitor induces rapid growth arrest and
blocks p70s6k activation by multiple stimuli J Biol Chem 275, 10796–10801
21 Mangues R, Corral T, Kohl NE, Symmans WF, Lu S, Malumbres M, Gibbs JB, Oliff A & Pellicer A (1998) Antitumor effect of a farnesyl protein transferase inhibi-tor in mammary and lymphoid tumors overexpressing N-ras in transgenic mice Cancer Res 58, 1253–1259
22 Miquel K, Pradines A, Terce F, Selmi S & Favre G (1998) Competitive inhibition of choline phosphotrans-ferase by geranylgeraniol and farnesol inhibits phospha-tidylcholine synthesis and induces apoptosis in human lung adenocarcinoma A549 cells J Biol Chem 273, 26179–26186
23 Anthony ML, Zhao M & Brindle KM (1999) Inhibition
of phosphatidylcholine biosynthesis following induction
of apoptosis in HL-60 cells J Biol Chem 274, 19686– 19692
24 Wright MM, Henneberry AL, Lagace TA, Ridgway
ND & McMaster CR (2001) Uncoupling farnesol-induced apoptosis from its inhibition of phosphatidyl-choline synthesis J Biol Chem 276, 25254–25261
25 Bi K, Roth MG & Ktistakis NT (1997) Phosphatidic acid formation by phospholipase D is required for transport from the endoplasmic reticulum to the Golgi complex Curr Biol 7, 301–307
26 Siddhanta A, Backer JM & Shields D (2000) Inhibition
of phosphatidic acid synthesis alters the structure of the Golgi apparatus and inhibits secretion in endocrine cells J Biol Chem 275, 12023–12031
27 Sweeney DA, Siddhanta A & Shields D (2002) Frag-mentation and re-assembly of the Golgi apparatus
in vitro A requirement for phosphatidic acid and phos-phatidylinositol 4,5-bisphosphate synthesis J Biol Chem
277, 3030–3039
28 Pilquil C, Singh I, Zhang QX, Ling ZC, Buri K, Strom-berg LM, Dewald J & Brindley DN (2001) Lipid phos-phate phosphatase-1 dephosphorylates exogenous lysophosphatidate and thereby attenuates its effects on cell signalling Prostagland Lipid Mediat 64, 83–92
29 Xu J, Zhang QX, Pilquil C, Berthiaume LG, Waggoner
DW & Brindley DN (2000) Lipid phosphate phospha-tase-1 in the regulation of lysophosphatidate signalling Ann NY Acad Sci 905, 81–90
30 Sciorra VA, Rudge SA, Wang J, McLaughlin S, Enge-brecht J & Morris AJ (2002) Dual role for phospho-inositides in regulation of yeast and mammalian phospholipase D enzymes J Cell Biol 159, 1039–1049
31 Colley WC, Sung TC, Roll R, Jenco J, Hammond SM, Altshuller Y, Bar-Sagi D, Morris AJ & Frohman MA (1997) Phospholipase D2, a distinct phospholipase D isoform with novel regulatory properties that provokes cytoskeletal reorganization Curr Biol 7, 191–201
32 Sung TC, Zhang Y, Morris AJ & Frohman MA (1999) Structural analysis of human phospholipase D1 J Biol Chem 274, 3659–3666
Trang 833 Sciorra VA & Morris AJ (1999) Sequential actions of
phospholipase D and phosphatidic acid
phosphohydro-lase 2b generate diglyceride in mammalian cells Mol
Biol Cell 10, 3863–3876
34 Escalante-Alcalde D, Hernandez L, Le Stunff H, Maeda
R, Lee HS Jr, Gang C, Sciorra VA, Daar I, Spiegel S,
Morris AJ et al (2003) The lipid phosphatase LPP3
regulates extra-embryonic vasculogenesis and axis
pat-terning Development 130, 4623–4637
35 Roberts R, Sciorra VA & Morris AJ (1998) Human
type 2 phosphatidic acid phosphohydrolases Substrate
specificity of the type 2a, 2b, and 2c enzymes and cell
surface activity of the 2a isoform J Biol Chem 273,
22059–22067
36 Mellor H & Parker PJ (1998) The extended protein
kinase C superfamily Biochem J 332, 281–292
37 Voziyan PA, Goldner CM & Melnykovych G (1993)
Farnesol inhibits phosphatidylcholine biosynthesis in
cultured cells by decreasing cholinephosphotransferase
activity Biochem J 295, 757–762
38 Voziyan PA, Haug JS & Melnykovych G (1995)
Mechanism of farnesol cytotoxicity: further evidence
for the role of PKC-dependent signal transduction in
farnesol-induced apoptotic cell death Biochem Biophys
Res Commun 212, 479–486
39 Quest AF, Ghosh S, Xie WQ & Bell RM (1997)
DAG second messengers: molecular switches and
growth control Adv Exp Medical Biol 400A, 297–
303
40 Le XF, Marcelli M, McWatters A, Nan B, Mills GB,
O’Brian CA & Bast RC Jr (2001) Heregulin-induced
apoptosis is mediated by down-regulation of Bcl-2 and
activation of caspase-7 and is potentiated by impairment
of protein kinase C alpha activity Oncogene 20, 8258–
8269
41 Wright MM & McMaster CR (2002) Phospholipid synthesis, diacylglycerol compartmentation, and apopto-sis Biol Res 35, 223–229
42 Hanauske AR, Sundell K & Lahn M (2004) The role of protein kinase C-alpha (PKC-alpha) in cancer and its modulation by the novel PKC-alpha-specific inhibitor aprinocarsen Curr Pharm Des 10, 1923–1936
43 Ruvolo PP, Deng X, Carr BK & May WS (1998) A functional role for mitochondrial protein kinase C alpha
in Bcl2 phosphorylation and suppression of apoptosis
J Biol Chem 273, 25436–25442
44 Ruvolo PP, Deng X & May WS (2001) Phosphorylation
of Bcl2 and regulation of apoptosis Leukemia 15, 515–522
45 Yang C & Kazanietz MG (2003) Divergence and com-plexities in DAG signaling: looking beyond PKC Trends Pharmacol Sci 24, 602–608
46 Tognon CE, Kirk HE, Passmore LA, Der Whitehead
IP, CJ & Kay RJ (1998) Regulation of RasGRP via a phorbol ester-responsive C1 domain Mol Cell Biol 18, 6995–7008
47 Dower NA, Stang SL, Bottorff DA, Ebinu JO, Dickie
P, Ostergaard HL & Stone JC (2000) RasGRP is essen-tial for mouse thymocyte differentiation and TCR signaling Nat Immunol 1, 317–321
48 Stone JC, Stang SL, Zheng Y, Dower NA, Brenner SE, Baryza JL & Wender PA (2004) Synthetic bryostatin analogues activate the RasGRP1 signaling pathway
J Med Chem 47, 6638–6644
49 Lowry OH, Rosebrough NJ, Farr AL & Randall RJ (1951) Protein measurement with the Folin phenol reagent J Biol Chem 193, 265–275
50 Ames BN & Dubin DT (1960) The role of polyamines
in the neutralization of bacteriophage deoxyribonucleic acid J Biol Chem 235, 769–775